Use of genomic data to predict lower than population risk of Breast and Colorectal Cancer.

Antoniou, A. C. and Easton, D. F. (2003) ‘Polygenic inheritance of breast cancer: Implications for design of association studies’, Genet Epidemiol, 25(3), pp. 190-202.

Asaria, M., Griffin, S., Cookson, R., Whyte, S. and Tappenden, P. (2015) ‘Distributional cost-effectiveness analysis of health care programmes–a methodological case study of the UK Bowel Cancer Screening Programme’, Health Econ, 24(6), pp. 742-54.

Bush, W. M., Jason. (2012) ‘Chapter 11: Genome-Wide Association Studies’, PLOS Computational Biology, Translational Bioinformatics, Available: @ploscompbiol. DOI: 10.1371/journal.pcbi.1002822 (Accessed 03/08/2017).

Choices, N. (2015) NHS cancer screening: Department of Health. Available at: 2017).

Choices, N. (2016) Breast cancer screening: Department of Health.

Collins, A. and Politopoulos, I. (2011) ‘The genetics of breast cancer: risk factors for disease’,  Appl Clin Genet, pp. 11-9.

Fadista, J., Manning, A. K., Florez, J. C. and Groop, L. (2016) ‘The (in)famous GWAS P-value threshold revisited and updated for low-frequency variants’, Eur J Hum Genet, 24(8), pp. 1202-5.

Gotzsche, P. C. and Jorgensen, K. J. (2013) ‘Screening for breast cancer with mammography’, Cochrane Database Syst Rev, (6), pp. Cd001877.

GOV.UK (2015) Population screening programmes: NHS breast screening (BSP) programme. Available at: (Accessed: 2017 01/05/2017).

Hall, P. S., Hamilton, P., Hulme, C. T., Meads, D. M., Jones, H., Newsham, A., Marti, J., Smith, A. F., Mason, H., Velikova, G., Ashley, L. and Wright, P. (2015) ‘Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data’, Br J Cancer, 112(5), pp. 948-56.

Hardy, J. and Singleton, A. (2009) ‘Genomewide Association Studies and Human Disease’,

Hindorff, L. A., Gillanders, E. M. and Manolio, T. A. (2011) ‘Genetic architecture of cancer and other complex diseases: lessons learned and future directions’, Carcinogenesis, 32(7), pp. 945-54.

Jenkins, J., Sellars, S. and Wheaton, M., Health, D.o.P. (2013) NHS Cancer Screening Programmes.

Kwok, P. Y. and Chen, X. (2003) ‘Detection of single nucleotide polymorphisms’, Curr Issues Mol Biol, 5(2), pp. 43-60.

Lalloo, F. and Evans, D. G. (2012) ‘Familial breast cancer’, Clin Genet, 82(2), pp. 105-14.

Lawless, G. D. (2009) ‘The working patient with cancer: implications for payers and employers’, Am Health Drug Benefits, 2(4), pp. 168-73.

Logan, R. F. A., Patnick, J., Nickerson, C., Coleman, L., Rutter, M. D. and Wagner, C. v. (2012) ‘Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests’.

Lomas, A., Leonardi-Bee, J. and Bath-Hextall, F. (2012) ‘A systematic review of worldwide incidence of nonmelanoma skin cancer’, Br J Dermatol, 166(5), pp. 1069-80.

Manolio, T. A., Feero, W. G. and Guttmacher, A. E. (2010) ‘Genomewide Association Studies and Assessment of the Risk of Disease’,

Marmot, M. G., Altman, D. G., Cameron, D. A., Dewar, J. A., Thompson, S. G. and Wilcox, M. (2013) ‘The benefits and harms of breast cancer screening: an independent review: A report jointly commissioned by Cancer Research UK and the Department of Health (England) October 2012’, Br J Cancer, 108(11), pp. 2205-40.

Mistry, M., Parkin, D. M., Ahmad, A. S. and Sasieni, P. (2011) ‘Cancer incidence in the United Kingdom: projections to the year 2030’, Br J Cancer, 105(11), pp. 1795-803.

Morton, R., Sayma, M. and Sura, M. S. (2017) ‘Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained?’, Breast Cancer (Dove Med Press), 9, pp. 217-225.

NICE (2017) Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer | Guidance and guidelines | NICE. Clinical Guideline CG164. UK: NICE. Available at: (Accessed: 29/07/2017 2017).

Peto, J. and Mack, T. M. (2000) ‘High constant incidence in twins and other relatives of women with breast cancer’, Nat Genet, 26(4), pp. 411-4.

Screening., I. U. P. o. B. C. (2012) ‘The benefits and harms of breast cancer screening: an independent review’, Lancet, 380(9855), pp. 1778-86.

Stadler, Z. K., Thom, P., Robson, M. E., Weitzel, J. N., Kauff, N. D., Hurley, K. E., Devlin, V., Gold, B., Klein, R. J. and Offit, K. (2010) ‘Genome-wide association studies of cancer’, J Clin Oncol, 28(27), pp. 4255-67.

Statistics, O. f. N. (2017) Cancer Registration Statistics, England: 2015. Cancer registration statistics Cancer Registration Statistics, England: 2015 Cancer diagnoses and age-standardised incidence rates for all cancer sites by age, sex and region.: Office for National Statistics. Available at: (Accessed: 15/07/2017 2017).

UK, B. C. (2017) Bowel cancer screening: @Bowel_Cancer_UK. Available at:

UK, C. R. (2015a) Bowel cancer risk factors. Available at: (Accessed: 01/05/2017 2017).

UK, C. R. (2015b) Breast cancer risk factors Breast cancer risks. Available at: (Accessed: 01/05/2017 2017).

UK, C. R. (2015c) Breast cancer statistics. Available at: (Accessed: 01/05/2017 2017).

UK, C. R. (2015d) Cancer-Research. Breast screening statistics: cancer research UK; 2015. Available at: (Accessed: 01/05/2017 2017).

Wray, N. R., Goddard, M. E. and Visscher, P. M. (2007) ‘Prediction of individual genetic risk to disease from genome-wide association studies’, Genome Res, 17(10), pp. 1520-8.


need two chapters.
1. on method, if you have a bioinformatics specialist who can run PLINK and some polygenic risk score analysis for me.
2. someone to write the discussion.

My deadline is Friday 15th september 9am!


Prime Essay Services , written from scratch, delivered on time, at affordable rates!